Check out today’s featured companies who have recently raised a round of funding, and be sure to check out the full list of past healthcare IT fundings.
InStride Announces $30M in Series C Funding
InStride, the most trusted, insurance-covered specialty program for young people living with complex anxiety, OCD, and related disorders, raised a $30M Series C from new strategic investors Echo Health Ventures and FMZ Ventures, with continued participation from existing backers: .406 Ventures, Valtruis, General Catalyst, and Mass General Brigham Ventures. The capital will fuel InStride’s expansion into new markets while deepening access in existing ones, ensuring more families can get the high-quality specialty care they need. InStride continues to demonstrate strong financial performance while sustaining the clinical quality that defines its model.
“We set out to prove that the highest-quality specialty care could also be the most scalable — and the data shows that’s exactly what we’ve built. This capital lets us go deeper in existing markets and broader into new ones, and Echo Health Ventures and FMZ Ventures are ideal partners for this next chapter alongside our existing investors. Clinical quality has always been at the center of everything we do, and that remains our true north,” said John Voith, Co-Founder and CEO at InStride.
The Most Trusted Program
Built on evidence-based care and expertise from the nation’s leading psychiatric hospital, our program pairs every young person with a family-centered team—including a psychiatrist, therapist, and exposure coach. Working alongside caregivers, schools, and pediatricians, these clinicians are supported by domain-specific AI designed to reinforce best practices, reduce variation, and scale consistent, high-quality care—while keeping clinical decision-making and relationships firmly in human hands.
Today, InStride operates in 17 states and has served 5,000+ patients, with national expansion underway…
Full release here, originally announced June 15th, 2026.
Former Palantir Healthcare Head Raises £10M for NHS AI Agent Startup
Frontier Health is Leveraging AI to Carry Out Administrative Tasks Which Burden the NHS
A London-based startup founded by a former Palantir healthcare executive who worked in NHS hospitals during Covid has raised £9.7M in a funding round.
The funding round in Frontier Health was led by Atomico, the European VC firm, with participation from XYZ Venture Capital and Firstminute Capital.
Frontier Health, which has raised £11.9m in total, is leveraging AI to carry out administrative tasks which are burdening patient care in the NHS.
The startup, founded in 2024, points to projected figures showing healthcare systems facing a 10m worker shortfall by 2030, saying that fixing the administrative burden behind patient care can reduce this worker shortfall. It was founded by Rachel Finegold, who worked as Palantir’s healthcare lead at 40 NHS hospitals during the COVID-19 pandemic.
She said she spent years working alongside NHS teams and saw first-hand how administrative bottlenecks impact patient outcomes.
Finegold, its CEO, told The Times, “There physically weren’t enough administrators to support this integral machinery that needs to happen to keep patients moving through the system and to get patients their care.”
Frontier Health has developed an AI agent, called Juno…
Full release here, originally announced June 18th, 2026.
No comments:
Post a Comment